ClinicalTrials.govpublic full text
Sodium Stibogluconate in the MDS/AML With One of the 65 Defined p53 Mutations
myelodysplastic syndromes, acute myeloid leukemia, myeloid malignancy, temperature-sensitive p53 mutation, sodium stibogluconate, p53 mutation, temperature-sensitive p53 mutations, p53, precision medicine, antimonial, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 877747
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.